See also this year's filing and all EDGAR filings for this company.
PDF Report 0001720893_2023_BioXcel_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001720893, BioXcel Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 202,868,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,084,000 |
| 3 | remainder_Assets | 1,901,000 |
| 4 | LiabilitiesCurrent | 32,898,000 |
| 5 | LiabilitiesNoncurrent | 93,837,000 |
| 6 | remainder_Liabilities | 2,343,000 |
| 7 | CostOfGoodsAndServicesSold | 20,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 68,761,000 |
| 9 | ResearchAndDevelopmentExpense | 91,239,000 |
| 10 | remainder_Expenses | 8,213,000 |
| 11 | remainder_Revenues | 375,000 |
| 12 | remainder_NetIncome | 2,101,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 205,853,000 |
| 1 | Liabilities | 129,078,000 |
| 2 | Expenses | 168,233,000 |
| 3 | Revenues | 375,000 |
| 4 | StockholdersEquity | 76,775,000 |
| 5 | NetIncome | -165,757,000 |
| 6 | ComprehensiveNetIncome | -165,757,000 |
| 7 | BaseVar | 252,820,000 |
| 8 | EconomicCapitalRatio | -0.201 |
Edgar->Model Mapping
Feature Distribution
Change over Time
